Efficacy and safety of bimatoprost in vitiligo: A randomized single-blinded controlled study
Phase 4
Recruiting
- Conditions
- Stable nonsegmental and segmental vitiligo lesions (for the last 3 months)Vitiligo,nonsegmental,segmental
- Registration Number
- TCTR20170526002
- Lead Sponsor
- Department of dermatology, Siriraj Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 25
Inclusion Criteria
1. Stable nonsegmental and segmental vitiligo lesions (for the last 3 months)
2. Without received any local treatment for vitiligo for at least 2 weeks before the study
3. Without received any photo therapy for vitiligo for at least 4 weeks before the study
Exclusion Criteria
1. Photosensitive patients, those with light aggravated dermatoses
2. Pregnant
3. Lactating females and patients with asthma or hypertension
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Efficacy of bimatoprost in the treatment of vitiligo 8 months Photographs, VASI Score, Extent of repigmentation,Efficacy of bimatoprost combined with targeted NB-UVB in the treatment of vitiligo 8 months Photographs, VASI Score, Extent of repigmentation
- Secondary Outcome Measures
Name Time Method Safety of bimatoprost in the treatment of vitiligo 8 months Patients' evaluation